Moderna refused China request to reveal vaccine technology – FT

Author of the article: Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter. The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request…
Moderna refused China request to reveal vaccine technology – FT

Author of the article:

Moderna Inc has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

Moderna did not immediately respond to Reuters’ request for comment.

China has not approved any foreign COVID-19 vaccines and relies on several domestically developed shots.

In September, Moderna Chief Medical Officer Paul Burton had said the company was keen to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

“We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there,” Burton had told a media briefing for reporters in Asia. “Currently, there is no activity going on, but we’d be very open to it.” (Reporting by Rhea Binoy in Bengaluru; editing by Jonathan Oatis)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Japanese stocks see second straight week of foreign inflows
Read More

Japanese stocks see second straight week of foreign inflows

Author of the article: Foreign investors bought Japanese stocks for a second straight week, as U.S. inflation data came in better than markets’ worst expectations and eased some concerns about broadening pricing pressures. Overseas investors net purchased Japanese stocks worth 86.68 billion yen in the week ended April 15, after buying 613.99 billion yen in…
Copper climbs on weaker dollar, demand hopes
Read More

Copper climbs on weaker dollar, demand hopes

BEIJING — Copper prices rose on Monday, supported by a weak U.S. dollar and hopes of better demand after top consumer China’s pledged to boost its economy and real estate sector. The most-traded January copper contract on the Shanghai Futures Exchange added 0.7% to 65,960 yuan ($9,455.28) a tonne. Financial Post Top Stories Sign up…
Britain backs offering monkeypox vaccine to broader population
Read More

Britain backs offering monkeypox vaccine to broader population

Author of the article: LONDON — British authorities are recommending gay and bisexual men at higher risk of exposure to monkeypox should be offered a vaccine, as the outbreak of the viral disease gathers pace in Europe. Although anyone can contract monkeypox, data from the ongoing outbreak suggests the majority of transmission is occurring within…